Cancer stem cell markers and uses thereof

Details for Australian Patent Application No. 2011208874 (hide)

Owner Glycotope GmbH

Inventors Goletz, Steffen; Karsten, Uwe

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011208874

PCT Pub. Number WO2011/089004

Priority 10 000 527.1 20.01.10 EP; 61/296,738 20.01.10 US

Filing date 20 January 2011

Wipo publication date 28 July 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/34 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/089004 Priority application(s): WO2011/089004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011208879-Method for the application of a conformal nanocoating by means of a low pressure plasma process

2011208855-Method and apparatus for detaching frozen charge from a tube mill